Latest News of TGTX
TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish
By Yahoo! Finance |
2 weeks ago
A list of the worst 52-week high stocks includes TG Therapeutics Inc. Despite positive results, the company faces high short interest due to concerns about drug competition and patent expiration. Fina...
TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
By Yahoo! Finance |
1 month ago
TG Therapeutics (TGTX) is a biopharmaceutical company excelling in treatments for B-cell mediated diseases, with a promising flagship product, Briumvi, targeting Multiple Sclerosis. The company's fina...
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 month ago
TG Therapeutics, Inc. is a biopharmaceutical company focusing on innovative treatments for B-cell mediated diseases. Their products include BRIUMVI for multiple sclerosis and Umbralisib for lymphoma. ...
-
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
By Yahoo! Finance | 3 months agoTG Therapeutics Inc is a biopharmaceutical company specializing in treatments for B-cell malignancies and autoimmune diseases. Insider selling trends, stock valuation metrics, and GF Value estimates s...